111 related articles for article (PubMed ID: 2676804)
1. [Progression of chronic renal failure. Pathogenesis and therapeutic aspects].
Teschner M; Heidland A
Fortschr Med; 1989 Aug; 107(24):515-8. PubMed ID: 2676804
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [The value of conservative treatment measures in treatment of chronic renal failure].
Schmicker R; Fröhling P
Z Urol Nephrol; 1989 Oct; 82(10):507-13. PubMed ID: 2692345
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of the progression of renal failure in glomerular diseases].
Ritz E; Siebels M; Fliser D
Internist (Berl); 1993 Apr; 34(4):330-9. PubMed ID: 8486477
[No Abstract] [Full Text] [Related]
5. [Post-transplant nephropathy and arterial hypertension].
Oko A; Idasiak-Piechocka I; Czekalski S
Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
7. [Factors of progression and chronic renal insufficiency and their prevention].
Ronco P
Bull Acad Natl Med; 1999; 183(1):65-77. PubMed ID: 10371766
[TBL] [Abstract][Full Text] [Related]
8. [Nephrology update--II. Causes and possibilities for modifying the progression of chronic renal failure].
Stein G; Sperschneider H; Fünfstück R; Haufe C
Med Klin (Munich); 1996 Apr; 91 Suppl 1():159-65. PubMed ID: 8657082
[No Abstract] [Full Text] [Related]
9. [Nephroprotection: how to slow the progression of chronic renal insufficiency?].
Hannedouche T; Krummel T; Parvez-Braun L
Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678
[TBL] [Abstract][Full Text] [Related]
10. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
11. [Management of patients with chronic renal failure].
Lang D; Kosch M; Schaefer RM
MMW Fortschr Med; 2005 Jan; 147(3):27-9, 31. PubMed ID: 15727110
[TBL] [Abstract][Full Text] [Related]
12. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
[No Abstract] [Full Text] [Related]
13. [Can we influence the progression of chronic kidney disease?].
Kuhlmann U; Hoyer J
Urologe A; 2009 Jul; 48(7):793-803; quiz 804-5. PubMed ID: 19590915
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive therapy in renal failure].
Mayer G
Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752
[TBL] [Abstract][Full Text] [Related]
15. Methods of cardio-renal protection in non-diabetic chronic nephropathies.
Ruggenenti P; Remuzzi G
Rocz Akad Med Bialymst; 2004; 49():116-23. PubMed ID: 15631326
[TBL] [Abstract][Full Text] [Related]
16. Phosphate is a uremic toxin.
Burke SK
J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
[TBL] [Abstract][Full Text] [Related]
17. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
Shohat J; Boner G
Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of patients with chronic renal insufficiency; a guideline for internists].
ter Wee PM; Jorna AT;
Ned Tijdschr Geneeskd; 2004 Apr; 148(15):719-24. PubMed ID: 15119205
[TBL] [Abstract][Full Text] [Related]
19. The progression of chronic renal disease: immunological, nutritional and intrinsic renal mechanisms.
Drukker A
Isr J Med Sci; 1997 Nov; 33(11):739-43. PubMed ID: 9434811
[TBL] [Abstract][Full Text] [Related]
20. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
